GEODE CAPITAL MANAGEMENT, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$13,168,098
-14.2%
2,415,879
+5.7%
0.00%0.0%
Q2 2023$15,343,266
-21.6%
2,286,626
+3.2%
0.00%
-33.3%
Q1 2023$19,567,112
+119269.9%
2,215,980
+3.3%
0.00%
+50.0%
Q4 2022$16,392
-99.9%
2,145,643
+4.7%
0.00%0.0%
Q3 2022$14,597,000
-11.1%
2,050,178
+1.0%
0.00%0.0%
Q2 2022$16,425,000
-16.3%
2,030,385
+43.5%
0.00%0.0%
Q1 2022$19,632,000
-51.4%
1,414,415
-1.7%
0.00%
-60.0%
Q4 2021$40,360,000
-14.7%
1,438,362
+3.3%
0.01%
-16.7%
Q3 2021$47,311,000
-1.0%
1,391,931
+19.0%
0.01%
-14.3%
Q2 2021$47,773,000
+9.6%
1,169,203
+8.0%
0.01%0.0%
Q1 2021$43,590,000
-28.8%
1,082,719
+4.5%
0.01%
-30.0%
Q4 2020$61,254,000
+28.4%
1,035,934
+5.6%
0.01%
+11.1%
Q3 2020$47,696,000
+83.9%
980,810
+82.9%
0.01%
+50.0%
Q2 2020$25,938,000
+99.8%
536,132
+14.7%
0.01%
+100.0%
Q1 2020$12,979,000
-4.3%
467,236
+3.1%
0.00%
+200.0%
Q4 2019$13,564,000
+92.3%
453,392
+98.6%
0.00%
-50.0%
Q3 2019$7,055,000228,3380.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders